A significant discovery in cancer study is arising with the use of VHH fragments to reactivate dysfunctional p53. This vital cancer protector protein is frequently inactivated in many types of malignancies, causing https://socialupme.com/story7638060/nanobodies-reactivate-the-p53-protein-the-potential-pathway-for-tumor-treatment